News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Lovell Stephanie
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/30/2023 |
4
| Lovell Stephanie (Director) has filed a Form 4 on TransMedics Group, Inc.|
Txns:
| Granted 1,193 shares
@ $0
Granted 1,916 options to buy
@ $71.33, valued at
$136.7k
|
|
| 11/23/2022 |
4
| Lovell Stephanie (Director) has filed a Form 4 on TransMedics Group, Inc.|
Txns:
| Sold 3,800 shares
@ $57.97, valued at
$220.3k
Sold 1,100 shares
@ $58.04, valued at
$63.8k
Sold 5,657 shares
@ $59.5, valued at
$336.6k
Exercised 3,800 options to buy
@ $47.82, valued at
$181.7k
Exercised 1,100 options to buy
@ $26.26, valued at
$28.9k
Exercised 5,657 options to buy
@ $47.82, valued at
$270.5k
|
|
| 06/16/2022 |
4
| Lovell Stephanie (Director) has filed a Form 4 on Cyclerion Therapeutics, Inc.|
Txns:
| Granted 20,000 options to buy
@ $0.53, valued at
$10.6k
|
|
| 06/06/2022 |
4
| Lovell Stephanie (Director) has filed a Form 4 on TransMedics Group, Inc.|
Txns:
| Granted 13,500 options to buy
@ $28.12, valued at
$379.6k
|
|
| 06/28/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/01/2021 |
4
| Lovell Stephanie (Director) has filed a Form 4 on TransMedics Group, Inc.|
Txns:
| Granted 2,250 options to buy
@ $26.26, valued at
$59.1k
|
|
| 03/24/2021 |
4
| Lovell Stephanie (Director) has filed a Form 4 on TransMedics Group, Inc.|
Txns:
| Granted 18,000 options to buy
@ $47.82, valued at
$860.8k
|
|
| 03/24/2021 |
3
| Lovell Stephanie (Director) has filed a Form 3 on TransMedics Group, Inc. |
| 06/18/2020 |
4
| Lovell Stephanie (Director) has filed a Form 4 on Cyclerion Therapeutics, Inc.|
Txns:
| Granted 10,000 options to buy
@ $4.46, valued at
$44.6k
|
|
| 06/04/2019 |
4
| Lovell Stephanie (Director) has filed a Form 4 on Cyclerion Therapeutics, Inc.|
Txns:
| Granted 10,000 options to buy
@ $13.95, valued at
$139.5k
|
|
| 04/03/2019 |
4
| Lovell Stephanie (Director) has filed a Form 4 on Cyclerion Therapeutics, Inc.|
Txns:
| Granted 2,421 shares
@ $0 |
|
| 04/03/2019 |
3
| Lovell Stephanie (Director) has filed a Form 3 on Cyclerion Therapeutics, Inc. |
|
|